Prediagnosis Psychiatric Care Linked to Worse Cancer Mortality
WEDNESDAY, March 13, 2019 -- Precancer psychiatric utilization (PU) is associated with worse cancer-specific mortality (CSM) and all-cause mortality (ACM) among adults with solid organ malignancies, according to a study recently published in the British Journal of Cancer.
Zachary Klaassen, M.D., from the University of Toronto, and colleagues included data for 676,125 residents of Ontario diagnosed with one of the top 10 malignancies from 1997 to 2014. The psychiatric utilization gradient (PUG) score was examined in the five years prior to cancer diagnosis (0: none; 1: outpatient; 2: emergency department; 3: hospital admission). The authors examined the impact of the PUG score on CSM and ACM.
The researchers found that 53.2, 45.0, 1.2, and 0.6 percent of patients had PUG scores of 0, 1, 2, and 3, respectively. An independent correlation was observed for increasing PUG score with worse CSM, with an effect gradient across the intensity of prediagnosis PU versus PUG 0 of 1.05, 1.36, and 1.73 for PUG 1, 2, and 3, respectively. A correlation was also noted for increasing PUG score with worse ACM.
"Patients with intense psychiatric utilization prior to diagnosis are more likely to suffer CSM compared to patients without psychiatric utilization," the authors write. "The specific factors underlying the observed associations remain to be elucidated."
© 2020 HealthDay. All rights reserved.
Posted: March 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.